Literature DB >> 22911924

Detecting anxiety symptoms in children and youths with neurofibromatosis type I.

Augusto Pasini1, Adriana Lo-Castro, Loredana Di Carlo, Mariabernarda Pitzianti, Martina Siracusano, Caterina Rosa, Cinzia Galasso.   

Abstract

Children with Neurofibromatosis type 1 (NF1) are known to have cognitive, social, and behavioral deficits. Fifteen NF1-subjects (5 boys, 10 girls, mean age = 13.4), and 15 healthy controls matched for age and sex were assessed on the presence of anxiety symptoms, using the Multidimensional Anxiety Scale for Children (MASC), self-report questionnaire. Significant group differences emerged with regard to MASC total (Z = -2.058, P = 0.041) and anxiety disorder index (ADI; Z = -2.202, P = 0.026), but not with regard to single scales. When the severity and visibility of NF1 were considered, correlation between severity and social anxiety, and severity and MASC total was found. This is the first study assessing anxiety symptoms in NF1 children and youths. A precocious psychological survey and intervention in NF1 subjects, may contribute to reduce the risk of psychiatric disorders in adulthood. 2012 Wiley Periodicals, Inc

Entities:  

Mesh:

Year:  2012        PMID: 22911924     DOI: 10.1002/ajmg.b.32095

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  10 in total

1.  Educational delay and attainment in persons with neurofibromatosis 1 in Denmark.

Authors:  Karoline Doser; Line Kenborg; Elisabeth Wreford Andersen; Pernille Envold Bidstrup; Anja Kroyer; Hanne Hove; John Østergaard; Sven Asger Sørensen; Christoffer Johansen; John Mulvihill; Jeanette Falck Winther; Susanne Oksbjerg Dalton
Journal:  Eur J Hum Genet       Date:  2019-02-28       Impact factor: 4.246

Review 2.  Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment.

Authors:  Shreya S Bellampalli; Rajesh Khanna
Journal:  Pain       Date:  2019-05       Impact factor: 6.961

3.  The Patients' Experiences of Burden of Neurofibromatosis: A Qualitative Study.

Authors:  Samira Foji; Eesa Mohammadi; Akram Sanagoo; Leila Jouybari
Journal:  Iran J Nurs Midwifery Res       Date:  2021-07-20

4.  The mediating effects of quality of life, depression, and generalized anxiety on perceived barriers to employment success for people diagnosed with Neurofibromatosis Type 1.

Authors:  Frank D Buono; Matthew E Sprong; Erina Paul; Staci Martin; Kaitlyn Larkin; Amir Garakani
Journal:  Orphanet J Rare Dis       Date:  2021-05-21       Impact factor: 4.123

Review 5.  Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

Authors:  Martha Milade Torres Nupan; Alberto Velez Van Meerbeke; Claudia Alejandra López Cabra; Paula Marcela Herrera Gomez
Journal:  Front Pediatr       Date:  2017-10-30       Impact factor: 3.418

6.  Worries and needs of adults and parents of adults with neurofibromatosis type 1.

Authors:  Andre B Rietman; Hanneke van Helden; Pauline H Both; Walter Taal; Jeroen S Legerstee; AnneLoes van Staa; Henriette A Moll; Rianne Oostenbrink; Agnies M van Eeghen
Journal:  Am J Med Genet A       Date:  2018-05       Impact factor: 2.802

7.  Glioma-Induced Seizure in a Neurofibromatosis Type 1 Patient: A Case Report.

Authors:  Jonathan Quinonez; Samir Ruxmohan; Sylvia Paesani; Abhinav Patel; Omo Edaki
Journal:  Cureus       Date:  2021-11-10

8.  A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India.

Authors:  Aditi Mahajan; Milind Patvekar; Samruddhi Lote; Mahendra Singh Deora; Divya Poulose; Jaya Madhurya Gogineni; Krish Panikar; Biswajit Chaklader
Journal:  Cureus       Date:  2022-02-19

9.  The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.

Authors:  Francesca Cervi; Veronica Saletti; Katherine Turner; Angela Peron; Sara Bulgheroni; Matilde Taddei; Francesca La Briola; Maria Paola Canevini; Aglaia Vignoli
Journal:  Orphanet J Rare Dis       Date:  2020-09-07       Impact factor: 4.123

10.  Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.

Authors:  Marie-Laure Armand; Charles Taieb; Aline Bourgeois; Mireille Bourlier; Mohammed Bennani; Christine Bodemer; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2019-05-03       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.